SARomics Biostructures AB:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:SARomics Biostructures AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10861
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SARomics Biostructures AB (Saromics) is a contract research organization that offers structural biology and drug discovery outsourcing services platform for biotech and pharmaceutical companies. The organization provides services in protein crystallization, protein crystallography, protein NMR spectroscopy and structure-based drug design. It offers protein and peptide optimization service which helps to predict the effect of a single amino acid replacement from data containing complex substitution patterns. Saromics also provides integrated drug discovery services including fragment screening based on chromatography ligand screening technology. The organization has operations in the US and Sweden. Saromics is headquartered in Lund, Sweden.

SARomics Biostructures AB – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SARomics Biostructures AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
SARomics Biostructures Enters into Distribution Agreement with Carna Biosciences 10
SARomics Biostructures Enters into Research Agreement with inSili.com 11
SARomics Enters Into Drug Discovery Agreement With Red Glead For FBLD Platform 12
SARomics Biostructures AB – Key Competitors 13
SARomics Biostructures AB – Key Employees 14
SARomics Biostructures AB – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Joint Venture 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Key Facts 2
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SARomics Biostructures AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SARomics Biostructures AB, Deals By Therapy Area, 2012 to YTD 2018 8
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
SARomics Biostructures Enters into Distribution Agreement with Carna Biosciences 10
SARomics Biostructures Enters into Research Agreement with inSili.com 11
SARomics Enters Into Drug Discovery Agreement With Red Glead For FBLD Platform 12
SARomics Biostructures AB, Key Competitors 13
SARomics Biostructures AB, Key Employees 14
SARomics Biostructures AB, Other Locations 15
SARomics Biostructures AB, Joint Venture 15

List of Figures
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
SARomics Biostructures AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[SARomics Biostructures AB:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Transport for London:企業の戦略的SWOT分析
    Transport for London - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • ATCC-製薬・医療分野:企業M&A・提携分析
    Summary ATCC is a nonprofit bioresource center and research organization that provides biological products, technical services and educational programs. The organization acquires, preserves, develops, authenticates, produces, and distributes standard reference microorganisms, cell lines and other ma …
  • Sonali Bank Limited:企業の戦略・SWOT・財務情報
    Sonali Bank Limited - Strategy, SWOT and Corporate Finance Report Summary Sonali Bank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Coloplast A/S:企業の戦略・SWOT・財務情報
    Coloplast A/S - Strategy, SWOT and Corporate Finance Report Summary Coloplast A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Kier Group Plc (KIE):電力:M&Aディール及び事業提携情報
    Summary Kier Group plc (Kier) is a construction and property development company specialized in residential and commercial property development, and infrastructure project investment. The company’s services portfolio include construction and civil engineering, support services, property development, …
  • Nila Infrastructures Ltd
    Nila Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report Summary Nila Infrastructures Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • IQVIA Holdings Inc (IQV):医療機器:M&Aディール及び事業提携情報
    Summary IQVIA Holdings Inc (IQVIA), formerly Quintiles IMS Holdings, Inc, is a provider of information, novel technological solutions and contract research services, by harnessing data and science, to healthcare companies. The company offers a wide range of solutions in clinical development, commerc …
  • Destiny Pharma Plc (DEST):製薬・医療:M&Aディール及び事業提携情報
    Summary Destiny Pharma Plc (Destiny Pharma), formerly Destiny Pharma Ltd, a subsidiary of Destiny Pharma Holdings Ltd is a drug development and discovery company that offers commercial exploitation and clinical development of the antibacterial products. The company provides XF drug platform to addre …
  • Philippine National Bank:企業の戦略・SWOT・財務分析
    Philippine National Bank - Strategy, SWOT and Corporate Finance Report Summary Philippine National Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Haplogen GmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Haplogen GmbH (Haplogen) is a biopharmaceutical company that improves human health by fighting against infectious diseases such as common cold, dengue fever, influenza and hepatitis C. The company utilizes its proprietary genetics technology platform to identify novel pathogen host factors a …
  • Holding Slovenske elektrarne doo:企業の戦略的SWOT分析
    Holding Slovenske elektrarne doo - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • National Thermal Power Corporation Ltd:戦略・SWOT・企業財務分析
    National Thermal Power Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary National Thermal Power Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Cabot Corp (CBT):企業の財務・戦略的SWOT分析
    Cabot Corp (CBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • One Medical Group Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary One Medical Group Inc (One Medical) is a provider of medical and technology-enabled health care services. The company’s service offerings include primary and pediatric care, prenatal and women's health, nutrition and sports medicine, LGBT care, mental health, dermatology, family and integrat …
  • ELMOS Semiconductor AG (ELG):企業の財務・戦略的SWOT分析
    ELMOS Semiconductor AG (ELG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Nephros Inc (NEPH):医療機器:M&Aディール及び事業提携情報
    Summary Nephros Inc (Nephros) is dialysis device manufacturer. The company offers infection control filters, dialysis ultrafilters, and hemodia filtration systems. Its dialysis ultrafilters includes Endotoxin ten Cartridge filter, SSUmini, DSU-D and SSU-D. Nephros dialysis ultrafilters are intended …
  • Sunovion Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Sunovion Pharmaceuticals Inc (Sunovion), a subsidiary of Sumitomo Dainippon Pharma Co Ltd, is a research-based pharmaceutical company. It discovers, develops and commercializes therapeutic products that focus on the treatment of central nervous system and respiratory disorders. Its product p …
  • Biosceptre International Ltd:企業の製品パイプライン分析2018
    Summary Biosceptre International Ltd (Biosceptre) is a biotechnology company that develops antibody technologies for applications in the diagnosis and treatment of cancer. The company develops imaging technologies to detect and monitor cancer. Its diagnostic products are used for the detection of va …
  • University of Arizona-医療機器分野:企業M&A・提携分析
    Summary University of Arizona (UA) is a healthcare research university that offers undergraduate and graduate degrees. The university’s academic departments include cancer biology graduate interdisciplinary program, cancer biology, cellular and molecular medicine, cancer center, center for education …
  • Coca-Cola Icecek A.S.:企業の戦略・SWOT・財務情報
    Coca-Cola Icecek A.S. - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola Icecek A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆